- Home
- CCJ vs VTR Comparison
CCJ vs VTR Comparison
Compare CCJ & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCJ
- VTR
- Stock Information
- Founded
- CCJ 1987
- VTR 1983
- Country
- CCJ Canada
- VTR United States
- Employees
- CCJ N/A
- VTR N/A
- Industry
- CCJ Other Metals and Minerals
- VTR Real Estate Investment Trusts
- Sector
- CCJ Basic Materials
- VTR Real Estate
- Exchange
- CCJ Nasdaq
- VTR Nasdaq
- Market Cap
- CCJ 25.2B
- VTR 27.3B
- IPO Year
- CCJ N/A
- VTR 1998
- Fundamental
- Price
- CCJ $58.84
- VTR $62.22
- Analyst Decision
- CCJ Strong Buy
- VTR Buy
- Analyst Count
- CCJ 4
- VTR 10
- Target Price
- CCJ $66.56
- VTR $60.40
- AVG Volume (30 Days)
- CCJ 4.7M
- VTR 2.6M
- Earning Date
- CCJ 11-07-2024
- VTR 10-30-2024
- Dividend Yield
- CCJ 0.19%
- VTR 2.91%
- EPS Growth
- CCJ N/A
- VTR N/A
- EPS
- CCJ 0.19
- VTR N/A
- Revenue
- CCJ $2,069,888,595.00
- VTR $4,797,115,000.00
- Revenue This Year
- CCJ $17.44
- VTR N/A
- Revenue Next Year
- CCJ $8.65
- VTR $7.07
- P/E Ratio
- CCJ $305.44
- VTR N/A
- Revenue Growth
- CCJ 23.31
- VTR 10.05
- 52 Week Low
- CCJ $35.43
- VTR $41.45
- 52 Week High
- CCJ $61.05
- VTR $67.61
- Technical
- Relative Strength Index (RSI)
- CCJ 60.92
- VTR 38.87
- Support Level
- CCJ $57.11
- VTR $63.09
- Resistance Level
- CCJ $60.78
- VTR $65.24
- Average True Range (ATR)
- CCJ 2.65
- VTR 0.98
- MACD
- CCJ 0.19
- VTR -0.14
- Stochastic Oscillator
- CCJ 77.26
- VTR 12.95
About CCJ Cameco Corporation
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. Cameco has three reportable segments, uranium, fuel services and Westinghouse. It derives maximum revenue from Uranium Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia and United States.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.